FEATURED/ARCHIVES (20/05/24)
×
Lurasidone Hydrochloride for Bipolar Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
×
Cost-Effectiveness Analysis of Physical Activity Interventions for People with Schizophrenia or Bipolar Disorder: Systematic Review · August 2023
Articles
British Journal of Psychiatry
×
Cost-Utility and Cost-Effectiveness of MoodSwings 2.0, an Internet-Based Self-Management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial · November 2022
Articles
JMIR Mental Health
×
Healthcare Resource Utilization, Costs and Treatment Patterns in Patients with Bipolar Disorder Treated with Lurasidone or Cariprazine · February 2021
Articles
Journal of Medical Economics